Clinical Trials Logo

Pre-hypertension clinical trials

View clinical trials related to Pre-hypertension.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02679248 Terminated - Pre-hypertension Clinical Trials

A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

15NBHN
Start date: February 3, 2016
Phase: Phase 2
Study type: Interventional

This study will investigate the effect of a nitric oxide supplementation product, Neo40 Daily®, on blood pressure in pre-hypertensive and mildly hypertensive adults. Subjects will take 2 lozenges per day 12 hours apart for 8 weeks. Half of the subjects will receive Neo40 Daily® and the other half of the subjects will receive placebo.

NCT ID: NCT01349114 Terminated - Hypertension Clinical Trials

Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects

Start date: June 2011
Phase: Phase 4
Study type: Interventional

The study will evaluate the effects of the direct renin inhibitor, aliskiren, on flow-mediated dilation of the brachial artery and on central aortic pressure in diabetic patients with pre-hypertension or Stage 1 hypertension.

NCT ID: NCT01025323 Terminated - Pre-Hypertension Clinical Trials

Study of Hispanics to Assess Risk Prevention in Prehypertension

SHARPP
Start date: December 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of lifestyle modification in reducing blood pressure values in Hispanics at risk for hypertension.

NCT ID: NCT00388388 Terminated - Pre-diabetes Clinical Trials

Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

Start date: March 2007
Phase: Phase 2
Study type: Interventional

This randomized, double-blind, parallel group, two-centre pilot study will test the hypothesis that subjects who are otherwise healthy but fulfill the criteria for a diagnosis of pre-hypertension and pre-diabetes will have regression or reduced progression of hypertension-associated changes in their resistance arteries if their blood pressure is controlled for 6 months with losartan, whereas similar subjects whose blood pressure is equally well controlled using hydrochlorothiazide will have significantly less improvement of the changes in their resistance arteries.